Mark Massaro
Stock Analyst at BTIG
(2.31)
# 2,511
Out of 4,754 analysts
137
Total ratings
49.57%
Success rate
n/a
Average return
Main Sectors:
Stocks Rated by Mark Massaro
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| ADPT Adaptive Biotechnologies | Maintains: Buy | $8 → $9 | $8.26 | +8.96% | 5 | Dec 18, 2024 | |
| EXAS Exact Sciences | Maintains: Buy | $65 → $75 | $47.41 | +58.19% | 16 | Nov 26, 2024 | |
| BNGO Bionano Genomics | Downgrades: Neutral | n/a | $4.16 | - | 8 | Sep 10, 2024 | |
| DNA Ginkgo Bioworks Holdings | Maintains: Sell | $0.2 → $7 | $8.24 | -15.05% | 6 | Aug 23, 2024 | |
| PSNL Personalis | Maintains: Buy | $5.5 → $7 | $4.14 | +69.08% | 1 | Aug 16, 2024 | |
| ZTS Zoetis | Maintains: Buy | $220 → $225 | $167.24 | +34.54% | 2 | Aug 12, 2024 | |
| NTRA Natera | Maintains: Buy | $125 → $135 | $155.59 | -13.23% | 13 | Aug 9, 2024 | |
| AKYA Akoya Biosciences | Downgrades: Neutral | n/a | $1.63 | - | 3 | Aug 6, 2024 | |
| WGS GeneDx Holdings | Maintains: Buy | $35 → $45 | $102.85 | -56.25% | 4 | Jul 31, 2024 | |
| GH Guardant Health | Maintains: Buy | $45 → $50 | $42.55 | +17.51% | 2 | Jul 30, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $580 | $437.11 | +32.69% | 1 | Jul 25, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $23 → $21 | $9.99 | +110.21% | 4 | May 2, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $10 → $8 | $3.34 | +139.52% | 3 | Mar 13, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | n/a | $6.50 | - | 1 | Mar 12, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $7 → $8 | $1.82 | +339.56% | 8 | Mar 7, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $7 → $8 | $3.67 | +117.98% | 2 | Mar 6, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $38 → $30 | $21.68 | +38.38% | 4 | Jun 15, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $6 → $5 | $3.46 | +44.51% | 3 | Mar 22, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $28 → $25 | $22.15 | +12.87% | 2 | Feb 28, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | n/a | $1.65 | - | 1 | Jan 20, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $5 → $3.5 | $1.48 | +136.49% | 2 | Nov 18, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $100 | $2.80 | +3,471.43% | 1 | Nov 30, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Neutral | n/a | $1.08 | - | 1 | Oct 8, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Hold | $350 → $300 | $88.74 | +238.07% | 6 | Sep 22, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Hold | $52 → $50 | $63.39 | -21.12% | 9 | Nov 11, 2019 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $108 → $112 | $172.90 | -35.22% | 10 | Jul 24, 2019 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Hold | $155 → $165 | $251.04 | -34.27% | 10 | May 2, 2019 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $78 → $80 | $39.99 | +100.05% | 9 | Sep 10, 2018 |
Adaptive Biotechnologies
Dec 18, 2024
Maintains: Buy
Price Target: $8 → $9
Current: $8.26
Upside: +8.96%
Exact Sciences
Nov 26, 2024
Maintains: Buy
Price Target: $65 → $75
Current: $47.41
Upside: +58.19%
Bionano Genomics
Sep 10, 2024
Downgrades: Neutral
Price Target: n/a
Current: $4.16
Upside: -
Ginkgo Bioworks Holdings
Aug 23, 2024
Maintains: Sell
Price Target: $0.2 → $7
Current: $8.24
Upside: -15.05%
Personalis
Aug 16, 2024
Maintains: Buy
Price Target: $5.5 → $7
Current: $4.14
Upside: +69.08%
Zoetis
Aug 12, 2024
Maintains: Buy
Price Target: $220 → $225
Current: $167.24
Upside: +34.54%
Natera
Aug 9, 2024
Maintains: Buy
Price Target: $125 → $135
Current: $155.59
Upside: -13.23%
Akoya Biosciences
Aug 6, 2024
Downgrades: Neutral
Price Target: n/a
Current: $1.63
Upside: -
GeneDx Holdings
Jul 31, 2024
Maintains: Buy
Price Target: $35 → $45
Current: $102.85
Upside: -56.25%
Guardant Health
Jul 30, 2024
Maintains: Buy
Price Target: $45 → $50
Current: $42.55
Upside: +17.51%
Jul 25, 2024
Initiates: Buy
Price Target: $580
Current: $437.11
Upside: +32.69%
May 2, 2024
Maintains: Buy
Price Target: $23 → $21
Current: $9.99
Upside: +110.21%
Mar 13, 2024
Maintains: Buy
Price Target: $10 → $8
Current: $3.34
Upside: +139.52%
Mar 12, 2024
Downgrades: Neutral
Price Target: n/a
Current: $6.50
Upside: -
Mar 7, 2024
Maintains: Buy
Price Target: $7 → $8
Current: $1.82
Upside: +339.56%
Mar 6, 2024
Maintains: Buy
Price Target: $7 → $8
Current: $3.67
Upside: +117.98%
Jun 15, 2023
Maintains: Buy
Price Target: $38 → $30
Current: $21.68
Upside: +38.38%
Mar 22, 2023
Maintains: Buy
Price Target: $6 → $5
Current: $3.46
Upside: +44.51%
Feb 28, 2023
Maintains: Buy
Price Target: $28 → $25
Current: $22.15
Upside: +12.87%
Jan 20, 2023
Downgrades: Neutral
Price Target: n/a
Current: $1.65
Upside: -
Nov 18, 2022
Maintains: Buy
Price Target: $5 → $3.5
Current: $1.48
Upside: +136.49%
Nov 30, 2020
Initiates: Buy
Price Target: $100
Current: $2.80
Upside: +3,471.43%
Oct 8, 2020
Initiates: Neutral
Price Target: n/a
Current: $1.08
Upside: -
Sep 22, 2020
Maintains: Hold
Price Target: $350 → $300
Current: $88.74
Upside: +238.07%
Nov 11, 2019
Maintains: Hold
Price Target: $52 → $50
Current: $63.39
Upside: -21.12%
Jul 24, 2019
Maintains: Buy
Price Target: $108 → $112
Current: $172.90
Upside: -35.22%
May 2, 2019
Maintains: Hold
Price Target: $155 → $165
Current: $251.04
Upside: -34.27%
Sep 10, 2018
Maintains: Buy
Price Target: $78 → $80
Current: $39.99
Upside: +100.05%